VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer

BACKGROUND: Anti-angiogenesis therapy that targets VEGF is one of the important treatment strategies in advanced ovarian cancer. However, depending on the pharmaceutical agent, treatment can have undesirable side effects. SEMA4D has recently gained interest for its role in promoting angiogenesis. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Zhang, Lei, Liu, Wen-xin, Wang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751932/
https://www.ncbi.nlm.nih.gov/pubmed/29308068
http://dx.doi.org/10.1186/s11658-017-0058-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751932/
https://www.ncbi.nlm.nih.gov/pubmed/29308068
http://dx.doi.org/10.1186/s11658-017-0058-9

Ejemplares similares